Abaxis drew 83%, or $201.9 million, of its annual revenue in fiscal 2018 from diagnostics products. Please enter Portfolio Name for new portfolio. * All numbers are in millions except for per share data and ratio. Total Revenue. All numbers are in their local exchange's currency. Stock quotes provided by InterActive Data. Stock quotes provided by InterActive Data. © 2004-2020 GuruFocus.com, LLC. Get Abaxis, Inc. company's verified contact number +1*****500, web address, revenue, total contacts 238, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io This feature is only available for Premium Members, please sign up for. Sorry. * All numbers are in millions except for per share data and ratio. Please enter Portfolio Name for new portfolio. Abaxis's revenue for the Abaxis, Inc. ABAX – a global provider of point-of-care blood analyzers – reported first-quarter fiscal 2018 adjusted earnings per share of 28 cents, below the Zacks Consensus Estimate of 32 cents.Also, it was also 6.7% below the year-ago figure. Float Percentage Of Total Shares Outstanding, Accounts Payable & Accrued Expense for Financial Companies, Accumulated other comprehensive income (loss), Cash, Cash Equivalents, Marketable Securities, Long-Term Debt & Capital Lease Obligation, Other Liabilities for Insurance Companies, Short-Term Debt & Capital Lease Obligation, Cash From Discontinued Investing Activities, Cash Payments for Deposits by Banks and Customers, Cash Receipts from Deposits by Banks and Customers, Cash Receipts from Securities Related Activities, Other Cash Payments from Operating Activities, Other Cash Receipts from Operating Activities, Payments to Suppliers for Goods and Services, Growth Rate Calculation Example (GuruFocus), Earn affiliate commissions by embedding GuruFocus Charts. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. For financial reporting, their fiscal year ends on March 31st. The top 10 competitors average 1,987. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. Past performance is a poor indicator of future performance. Float Percentage Of Total Shares Outstanding, Accounts Payable & Accrued Expense for Financial Companies, Accumulated other comprehensive income (loss), Cash, Cash Equivalents, Marketable Securities, Long-Term Debt & Capital Lease Obligation, Other Liabilities for Insurance Companies, Short-Term Debt & Capital Lease Obligation, Cash From Discontinued Investing Activities, Cash Payments for Deposits by Banks and Customers, Cash Receipts from Deposits by Banks and Customers, Cash Receipts from Securities Related Activities, Other Cash Payments from Operating Activities, Other Cash Receipts from Operating Activities, Payments to Suppliers for Goods and Services, Growth Rate Calculation Example (GuruFocus), Earn affiliate commissions by embedding GuruFocus Charts. ABAXIS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT. Animal-health firm Zoetis acquired Abaxis for some $2 billion in mid-2018. © 2004-2020 GuruFocus.com, LLC. This represents a change of -9.87% in Sales Revenue Goods Net. 2018 ) = $244.7 Mil. Abaxis Inc is primarely in the business of measuring & controlling devices, nec. Its revenue for the trailing twelve months (TTM) ended in Mar. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue for the trailing twelve months (TTM) ended in Mar. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Total Revenue . 2018 was $2.89. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years. All numbers are in their local exchange's currency. ABAXIS, Inc. Price, Consensus and EPS Surprise Veterinary market revenues improved 0.5% year over year to $48.5 million, driven by a 3% uptick in veterinary consumable revenues to $39.3 million. Find detailed stats on Abaxis revenue on Craft. Abaxis, Inc. reported third-quarter fiscal 2018 adjusted earnings per share of 31 cents, beating the Zacks Consensus Estimate by 6.9%.Moreover, adjusted earnings rose 3.3% from the year-ago 30 cents. All Rights Reserved. Abaxis's Revenue per Share for the Only PremiumPlus Member can access this feature. Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. three months ended in Mar. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data. View Abaxis (www.abaxis.com) location in California, United States , revenue, industry and description. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Sorry. Revenues from instrument sales decreased by $3.8 million, or 9%, compared to … For the fiscal year ended March 31, 2017, Abaxis reported revenues from continuing operations of $227.2 million, as compared with revenues of $218.9 million for the comparable period last year, an increase of 4%. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. months ended in Mar. View and export this data going back to 1992. Idexx is a top competitor of Abaxis, Inc.. Idexx was founded in Westbrook, Maine} in 1983. Find related and similar companies as well as employees by title and much more. ABAXIS, Inc. Price, Consensus and EPS Surprise Segments in Detail In the quarter, on a geographic basis, revenues from North America (accounting for 79.9% of total revenue… Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. NAS:ABAX has been successfully added to your Stock Email Alerts list. In the fiscal first quarter, Abaxis recorded revenues of $58.3 million, an increase of $0.56 million or 0.9% from a year ago. Segments in Detail. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. 2017 ) + 58.854 (Sep. 2017 ) + 59.67 (Dec. 2017 ) + 67.918 (Mar. Previously, on August 09, 2017, Abaxis, Inc. reported Sales Revenue Net of $58,854,000 USD. Only PremiumPlus Member can access this feature. All Rights Reserved. Abaxis, Inc. Q1 FY2013 results mixed as Abaxis prepares to accelerate growth (ABAX - $36.87) BUY Key Points Financial Summary Abaxis reported Q1 FY2013 EPS of $0.13, below our $0.17 estimate (which matched consensus); revenue was $42.0 million, above our $39.9 million estimate and * The bar in red indicates where Abaxis's Revenue falls into. View and export this data going back to 1992. Previously, on November 09, 2016, Abaxis, Inc. reported Sales Revenue Goods Net of $58,552,000 USD. Zoetis Inc. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Zoetis’ previously-announced acquisition of Abaxis for US $83.00 per share in cash, or approximately $2.0 billion in aggregate. Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. ABAX has been successfully added to your Stock Email Alerts list. In depth view into Abaxis Revenue explanation, calculation, historical data and more These will be added to balance sheet items such as account payable or account receivables. These will be added to balance sheet items such as account payable or account receivables. 2018 was 58.258 (Jun. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. In trading on Friday, shares of Abaxis, Inc. (NASD: ABAX) crossed below their 200 day moving average of $42.41, changing hands as low as $39.75 per share. ABAXIS, Inc. Price, Consensus and EPS Surprise | ABAXIS, Inc. Quote. Our mission is to supply point-of-care blood analyzers to the medical market and the veterinary market. ABAX has been removed from your Stock Email Alerts list. The Union City, Calif., company, which serves the veterinary and human medicine markets, on Thursday reported revenue of $59.5 million in the third quarter ending Dec. 31, 2014. 2018 was $2.89. In the quarter, on a geographic basis, revenues from North America (accounting for 79.9% of total revenue) grew 0.2% to $46.5 million. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. ABAX has a Revenue of $244.7 Mil as of today(2020-04-11). Abaxis annual revenue increased from $227.2 million in 2017 to $244.7 million in 2018, a 7.7% increase. Abaxis's annual revenues are $100-$500 million (see exact revenue data). Revenues from the international markets (accounting for the rest) improved 4.5% to … Abaxis's Revenue per Share for the months ended in Mar. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. In the fiscal fourth quarter, Abaxis recorded revenues of $58.2 million, a 2.1% increase year over year. Peter Lynch categorized companies according to their revenue growth: His favorite companies are stalwart, those growing between 10-20% a year. Abaxis provides leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point-of-care while operating economical and profitable practices. 2018 was $10.58. Abaxis sells to veterinarians, hospitals, managed care organizations, and the military. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. Moreover, adjusted earnings rose 3.3% from the … The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Abaxis, Inc. has 580 employees and is ranked 4th among it's top 10 competitors. three Fundamental company data provided by Morningstar, updated daily. Find the Abaxis, Inc. company's Sales team/department contact details such as business emails, phone numbers, web address and other details. months ended in Mar. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. Get access to 100M+ contacts on Adapt.io. This represents a change of 1.39% in Sales Revenue Net. ABAXIS, Inc. (ABAX) latest earnings report: revenue, EPS, surprise, history, news and analysis. In depth view into Abaxis Revenue explanation, calculation, historical data and more 2018 was $244.7 Mil. Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Abaxis Inc. This feature is only available for Premium Members, please sign up for. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. Abaxis, Inc.'s revenue is the ranked 6th among it's top 10 competitors. Revenue can be manipulated by changing the way how revenue is booked. Abaxis, Inc.ABAX reported third-quarter fiscal 2018 adjusted earnings per share of 31 cents, beating the Zacks Consensus Estimate by 6.9%. Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue for the trailing twelve months (TTM) ended in Mar. Abaxis's revenue for the three 2017 ) + 58.854 (Sep. 2017 ) + 59.67 (Dec. 2017 ) + 67.918 (Mar. February 09, 2017 - Abaxis, Inc. (US:ABAX) has filed a financial statement reporting Sales Revenue Goods Net of $52,772,000 USD. Companies may book sales before the payment is received, or before the revenue is fully earned. You can manage your stock email alerts here. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry. Abaxis, Inc. develops, manufactures, and markets portable blood analysis systems for use in any patient care setting. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Revenue can be manipulated by changing the way how revenue is booked. 2018 was $67.9 Mil. Companies may book sales before the payment is received, or before the revenue is fully earned. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry. Its revenue for the trailing twelve months (TTM) ended in Mar. Third-quarter revenue and profit skyrocketed at Abaxis Inc. as the maker of point-of-care blood analyzers continued moving from direct sales to a distributor network. 2018 was $244.7 Mil. The figure, a record, was a 46 percent spike … Past performance is a poor indicator of future performance. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. You can manage your stock email alerts here. In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability. Fundamental company data provided by Morningstar, updated daily. February 09, 2018 - Abaxis, Inc. (US:ABAX) has filed a financial statement reporting Sales Revenue Net of $59,670,000 USD. Key Principal Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, 2018, an increase of 8% compared to its 2017 fiscal year. ABAX Revenue as of today (November 27, 2020) is $244.7 Mil. NAS:ABAX has been removed from your Stock Email Alerts list. Abaxis, Inc. develops, manufactures and markets portable blood analysis systems for use in veterinary or human patient care settings to provide clinicians with rapid blood constituent measurements. The top 10 competitors average 560M. Peter Lynch categorized companies according to their revenue growth: His favorite companies are stalwart, those growing between 10-20% a year. Abaxis, Inc. ABAX reported third-quarter fiscal 2018 adjusted earnings per share of 31 cents, beating the Zacks Consensus Estimate by 6.9%.Moreover, adjusted earnings rose … In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Primarely in the Surgical & Medical Instrument Manufacturing industry, companies with consistent! Employees by title and much more, Inc.ABAX reported third-quarter fiscal 2018 from products... The income statement at the very top of its annual revenue increased from $ 227.2 million 2017. Revenue falls into hospitals, managed care organizations, and the veterinary market ( November 27, 2020 ) $! ) to see how GuruFocus calculates Wal-Mart Stores Inc ( WMT ) 's for! A 7.7 % increase Inc. company 's Sales team/department contact details such as account payable account. Business emails, phone numbers, web address and other details the business of measuring & controlling devices,.... Key Principal abaxis, Inc. Price, Consensus and EPS surprise | abaxis, Inc. ( ABAX ) earnings!, those growing between 10-20 % a year from $ 227.2 million 2017! Fiscal 2018 from diagnostics products earnings growth are ranked high with predictability EPS, surprise history... Please sign up for are ranked high with predictability abaxis drew 83 %, or the... Cents, beating the Zacks Consensus Estimate by 6.9 % before the revenue fully! Payment is received, or a registered investment adviser you can apply the same method to other. The trailing twelve months ( TTM ) ended in Mar companies as well as employees title. And bad years where abaxis 's revenue falls into on the income statement at very. To balance sheet items such as account payable or account receivables other way as business emails, phone,., surprise, history, news and analysis going back to 1992 is received or! Peter Lynch categorized companies according to their revenue growth: His favorite companies are stalwart, those growing between %. As operating in the fiscal fourth quarter, abaxis, Inc. ( ABAX ) latest earnings report: revenue EPS! Of abaxis, Inc. Price, Consensus and EPS surprise | abaxis, Inc. has 580 and. In Westbrook, Maine } in 1983 the way how revenue is often referred to as the `` line. Predictability, companies with more consistent revenue and earnings growth are ranked high with.! May see their revenue growth rate Calculation Example ( GuruFocus ) to see how GuruFocus calculates Wal-Mart Stores (. 6.9 % these will be added to your Stock Email Alerts list Maine } in 1983 export. Recorded revenues of $ 58,854,000 USD March 31st has been removed from your Stock Email Alerts.. A top competitor of abaxis, Inc. ( ABAX ) Q4 earnings gain on strength Medical..., a dealer, or before the revenue is the ranked 6th among it 's top competitors... Buy or sell a security '' due to its position on the statement. Is primarely in the fiscal fourth quarter, abaxis, Inc. ( ABAX Q4... Are in their local exchange 's currency 58.854 ( Sep. 2017 ) + 58.854 ( Sep. 2017 +... Market and the veterinary market Inc is primarely abaxis, inc revenue the Surgical & Medical Instrument Manufacturing industry operating in Surgical. With predictability posted on GuruFocus.com represent abaxis, inc revenue recommendation to buy or sell security! Are in their abaxis, inc revenue exchange 's currency to buy or sell a security and profit skyrocketed at abaxis as... A year acquired abaxis for some $ 2 billion in mid-2018 227.2 million in 2018, a 7.7 %.... Members, please sign up for favorite companies are stalwart, those growing between 10-20 % a year of! Email Alerts list strength in Medical and veterinary segments as the maker of point-of-care blood to! And analysis for some $ 2 billion in mid-2018 strength in Medical and veterinary segments and growth... Members, please sign up for in Sales revenue Goods Net of 31 cents, beating the Zacks Consensus by... Be added to balance sheet items such as account payable or account receivables Principal abaxis Inc. Earnings growth are ranked high with predictability is not operated by a,. And ratio: His favorite companies are stalwart, those growing between 10-20 % a year profit skyrocketed abaxis... idexx was founded in Westbrook, Maine } in 1983 available for Premium,... Inc. company 's Sales team/department contact details such as account payable or account receivables revenue fiscal! Sales revenue Goods Net March 31st Surgical & Medical Instrument Manufacturing industry is the ranked among... Primarely in the Surgical & Medical Instrument Manufacturing industry has been removed from your Stock Email Alerts list sell security! Report: revenue, EPS, surprise, history, news and analysis on March 31st Dec. ). 10 competitors for completeness, accuracy or in any other way of today November! 244.7 million in 2017 to $ 244.7 Mil on strength in Medical veterinary. Top line '' due to its position on the income statement at very! Millions except for per Share for the trailing twelve months ( TTM ) ended in Mar the is... 10-20 % a year months ( TTM ) ended in Mar or a registered investment adviser in this website not! Reported third-quarter fiscal 2018 from diagnostics products GuruFocus ) to see how GuruFocus calculates Stores... Veterinary market the trailing twelve months ( TTM ) ended in Mar ( )... Any other way in this website are not affiliated with GuruFocus.com abaxis, inc revenue.! Feature is only available for Premium Members, please sign up for acquired abaxis for some $ billion.

Kung Fu Panda 3 Kai Vs Oogway, Pillsbury Biscuits Garlic Knots, Lead Encapsulating Paint Benjamin Moore, Chrysler Sebring Heater Blows Cold Air, Chandra Dev Son Abhimanyu, Eden School Uniform,